AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.
WSJ.com: What's News US, Wall Street Journal: Home US
Fri, 07/25/2014 - 5:44am
AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.